FI931882A0 - Cykliska iminoderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel - Google Patents

Cykliska iminoderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel

Info

Publication number
FI931882A0
FI931882A0 FI931882A FI931882A FI931882A0 FI 931882 A0 FI931882 A0 FI 931882A0 FI 931882 A FI931882 A FI 931882A FI 931882 A FI931882 A FI 931882A FI 931882 A0 FI931882 A0 FI 931882A0
Authority
FI
Finland
Prior art keywords
iminoderivat
cee
cyclic
foerfarande foer
deras framstaellning
Prior art date
Application number
FI931882A
Other languages
English (en)
Other versions
FI931882A (fi
Inventor
Guenter Linz
Volkhard Austel
Frank Himmelsbach
Johannes Weisenberger
Thomas Mueller
Helmut Pieper
Elke Seewaldt-Becker
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI931882A0 publication Critical patent/FI931882A0/fi
Publication of FI931882A publication Critical patent/FI931882A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
FI931882A 1992-04-28 1993-04-27 Cykliska iminoderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel FI931882A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4213931A DE4213931A1 (de) 1992-04-28 1992-04-28 Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FI931882A0 true FI931882A0 (fi) 1993-04-27
FI931882A FI931882A (fi) 1993-10-29

Family

ID=6457642

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931882A FI931882A (fi) 1992-04-28 1993-04-27 Cykliska iminoderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel

Country Status (14)

Country Link
US (1) US5489693A (fi)
EP (1) EP0567968A1 (fi)
JP (1) JPH0625159A (fi)
KR (1) KR930021615A (fi)
AU (1) AU659933B2 (fi)
CA (1) CA2094964A1 (fi)
DE (1) DE4213931A1 (fi)
FI (1) FI931882A (fi)
HU (1) HU9301223D0 (fi)
IL (1) IL105518A0 (fi)
MX (1) MX9302459A (fi)
NO (1) NO931527L (fi)
NZ (1) NZ247502A (fi)
PL (1) PL298718A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018058A1 (en) * 1992-03-06 1993-09-16 G.D. Searle & Co. Peptides mimics useful as platelet aggregation inhibitors
CA2093994A1 (en) * 1992-04-16 1993-10-17 Albert C. Chiang Electrically conductive and semi-conductive polymers
DE4241632A1 (de) * 1992-12-10 1994-06-16 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
ES2150489T3 (es) * 1993-03-31 2000-12-01 Searle & Co 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
AU6318896A (en) * 1995-07-06 1997-02-05 Japan Tobacco Inc. Benzamidoxime derivatives and medicinal use thereof
JP2003504301A (ja) 1998-04-01 2003-02-04 ブリストル−マイヤーズ スクイブ ファーマ カンパニー インテグリンアンタゴニスト
CA2345210A1 (en) 1998-11-18 2000-05-25 Prabhakar Kondaji Judhav Novel isoxazoline fibrinogen receptor antagonists
US6319937B1 (en) 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
DE19936789A1 (de) * 1999-08-09 2001-03-01 Vectron Therapeutics Ag Neue Pyrrolidinole und ihre Verwendung für die Tumortherapie
US8222341B2 (en) 2009-03-17 2012-07-17 Mearthane Products Corporation Semi-conductive silicone polymers
CN102206178B (zh) * 2010-03-30 2013-04-10 上海源力生物技术有限公司 制备艾瑞昔布的方法
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123288A (en) * 1982-07-16 1984-02-01 Wellcome Found Anti-thrombotic agent
EP0196184B1 (en) * 1985-03-16 1992-09-16 The Wellcome Foundation Limited Aryl derivatives
DE3823299A1 (de) * 1988-07-07 1990-01-11 Schering Ag Substituierte phenyl-pyrrolidin-2-one, -oxazolidin-2-one und -imidazolidin-2-one, ihre herstellung sowie verwendung in arzneimitteln
JPH02247166A (ja) * 1989-03-17 1990-10-02 Taisho Pharmaceut Co Ltd ３―ピロリン―２―オン誘導体
US5026861A (en) * 1989-07-17 1991-06-25 Merrell Dow Pharmaceuticals Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones
AU632963B2 (en) * 1990-09-07 1993-01-14 Mitsui Toatsu Chemicals Inc. 3,4-trans-4-ethyl-1-(substituted phenyl)-3-(substituted phenyl)pyrrolidin-2-ones, method for preparing the same, and herbicidal compositions containing the same as herbicidally active ingredients
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4107857A1 (de) * 1991-03-12 1992-09-17 Thomae Gmbh Dr K Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NZ247502A (en) 1995-09-26
PL298718A1 (en) 1994-01-24
EP0567968A1 (de) 1993-11-03
AU3822393A (en) 1993-11-04
DE4213931A1 (de) 1993-11-04
US5489693A (en) 1996-02-06
HU9301223D0 (en) 1993-07-28
CA2094964A1 (en) 1993-10-29
IL105518A0 (en) 1993-08-18
NO931527L (no) 1993-10-29
NO931527D0 (no) 1993-04-27
MX9302459A (es) 1994-06-30
JPH0625159A (ja) 1994-02-01
AU659933B2 (en) 1995-06-01
FI931882A (fi) 1993-10-29
KR930021615A (ko) 1993-11-22

Similar Documents

Publication Publication Date Title
FI930620A (fi) Bensimidazolylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI933942A (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI900192A0 (fi) Cykliska aminfoereningar och deras anvaendning.
FI931427A (fi) Ny onkofetal gen, genprodukt och anvaendningen daerav
FI924801A0 (fi) Foerfarande, mobiltelefoncentral och foermedlingssystem foer att saenda kortmeddelande i ett sellulartradiosystem
FI933472A0 (fi) Peptider med foermaoga att inhibera effekten av hiv-proteas, deras framstaellning och terapeutiska anvaendning
FI932625A0 (fi) Anordning och foerfarande foer detektering av ytfel i laonga, i roerelse befintliga metallprodukter
FI931291A0 (fi) Indol- och indazolderivat foer behandling och foerebyggande av hjaernsjukdomar, deras framstaellning och anvaendning
FI931882A (fi) Cykliska iminoderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI922004A0 (fi) Maetningsfoerfarande och maetanordning.
FI922390A (fi) Initiatorsuspensioner, deras framstaellning och anvaendning
FI922491A (fi) Foerbaettrad, fosfat och enzymer innehaollande, pulverformig diskmedelskomposition foer automatiska diskmaskiner
FI935829A0 (fi) Anlaeggning och foerfarande foer uttnyttjning av braennbara aemnen, speciellt industri- och hushaollsavfall
FI934302A0 (fi) Kaerngarn, son innehaoller en kaerna av ytterst haollbart polyestermaterial, foerfarande foer framstaellning av dessa och anvaendning av valda polyestermaterial foer framstaellning av kaerngarn
FI934221A0 (fi) Piperidinderivat, framstaellning och terapeutisk anvaendning daerav
FI922492A (fi) Fosfat och enzymer innehaollande, pulverformig diskmedelskomposition foer automatiska diskmaskiner
FI922377A (fi) Glasblandning, daerav framstaellda glasfibrer och deras framstaellningsfoerfarande
FI931682A0 (fi) Tackykininreceptorantagonister, isokinoloner och deras framstaellning
FI935132A0 (fi) Fenolisk resolfanerharts, foerfarande och tillverkning
FI48U1 (fi) Anordning foer ljus, vaser och dylika
FI924974A0 (fi) Foerfarande och anordning foer framstaellning av nytt, foer massaindustrius bruk avsett fibermaterial av vanligt stock- och fiberraomaterial
FI932408A (fi) Foerfarande foer foeraendring av deinkade returpappersmassors egenskaper, saerskilt fiberfraktion, och maskinsats foer genomfoerande av detta foerfarande
FI922899A0 (fi) Foerfarande och medel foer att skydda maenniskan foer solens uv-straolning.
FI922063A0 (fi) Foerfarande och anordning foer dynamisk injektering i syfte att taeta och foerstaerka bergkonstruktioner.
FI920510A0 (fi) Hjulburen anordning foer anvaendning i traedgaordar och liknande.

Legal Events

Date Code Title Description
FD Application lapsed